A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Business description not available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 53M | 53M | 55M | 55M | 68M | 63M |
| Net Income | 11M | 11M | 12M | 10M | 16M | 11M |
| EPS | $0.17 | $0.17 | $0.21 | $0.17 | $0.26 | $0.18 |
| Free Cash Flow | 12M | 12M | 23M | 7.5M | 19M | 17M |
| ROIC | 87.1% | 63.9% | 101.6% | 43.2% | 73.8% | 63.8% |
| Gross Margin | 71.8% | 71.8% | 72.8% | 71.5% | 71.6% | 71.2% |
| Debt/Equity | 0.00 | 0.14 | 0.18 | 0.24 | 0.13 | 0.26 |
| Dividends/Share | $0.21 | $0.21 | $0.11 | $0.32 | $0.07 | $0.00 |
| Operating Income | 14M | 14M | 18M | 14M | 16M | 11M |
| Operating Margin | 26.6% | 26.6% | 32.3% | 24.5% | - | - |
| ROE | 31.1% | 31.1% | 36.9% | 34.5% | 37.0% | 36.0% |
| Shares Outstanding | 62M | 62M | 59M | 60M | 61M | 59M |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 63M | 68M | 55M | 55M | 53M | 53M |
| Gross Margin | 71.2% | 71.6% | 71.5% | 72.8% | 71.8% | 71.8% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | 11M | 16M | 14M | 18M | 14M | 14M |
| Op. Margin | N/A | N/A | 24.5% | 32.3% | 26.6% | 26.6% |
| Net Income | 11M | 16M | 10M | 12M | 11M | 11M |
| Net Margin | 17.0% | 23.2% | 18.4% | 22.4% | 20.0% | 20.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||
| ROIC | 63.8% | 73.8% | 43.2% | 101.6% | 63.9% | 87.1% |
| ROE | 36.0% | 37.0% | 34.5% | 36.9% | 31.1% | 31.1% |
| ROA | 22.0% | 27.3% | 22.5% | 23.1% | 23.2% | 23.2% |
| Cash Flow | ||||||
| Op. Cash Flow | 17M | 19M | 7.5M | 23M | 12M | 12M |
| Free Cash Flow | 17M | 19M | 7.5M | 23M | 12M | 12M |
| Owner Earnings | 13M | 16M | 5.1M | 20M | 10M | 10M |
| CapEx | 0 | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 3.7M | 2.9M | 2.4M | 2.5M | 2.1M | 2.1M |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | 0 |
| D&A | 3.7M | 2.9M | 2.4M | 2.5M | 2.1M | 2.1M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||
| Dividends Paid | 0 | 4.2M | 19M | 6.5M | 13M | 13M |
| Dividend Yield | N/A | 3.3% | 17.1% | 5.8% | 11.6% | 8.0% |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 1.8M | 4.4M | 4.4M |
| Balance Sheet | ||||||
| Net Debt | -17M | -26M | -5.8M | -21M | -18M | -22M |
| Cash & Equiv. | 25M | 32M | 13M | 26M | 22M | 22M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | 0.26 | 0.13 | 0.24 | 0.18 | 0.14 | 0.00 |
| Interest Coverage | 51.7 | 134.6 | 62.4 | 26.4 | 22.1 | 22.1 |
| Equity | 30M | 43M | 29M | 33M | 34M | 34M |
| Total Assets | 49M | 58M | 45M | 53M | 46M | 46M |
| Total Liabilities | 19M | 15M | 16M | 20M | 12M | 12M |
| Intangibles | 0 | 0 | 0 | 482K | 401K | 401K |
| Retained Earnings | 0 | 0 | 18M | 22M | 25M | 25M |
| Working Capital | 27M | 34M | 20M | 23M | 23M | 23M |
| Current Assets | 38M | 44M | 28M | 37M | 30M | 30M |
| Current Liabilities | 11M | 9.5M | 8.8M | 14M | 7.0M | 7.0M |
| Per Share Data | ||||||
| EPS | 0.18 | 0.26 | 0.17 | 0.21 | 0.17 | 0.17 |
| Owner EPS | 0.22 | 0.27 | 0.08 | 0.34 | 0.17 | 0.17 |
| Book Value | 0.51 | 0.70 | 0.49 | 0.56 | 0.56 | 0.56 |
| Cash Flow/Share | 0.25 | 0.31 | 0.21 | 0.25 | 0.21 | 0.21 |
| Dividends/Share | 0.00 | 0.07 | 0.32 | 0.11 | 0.21 | 0.21 |
| Shares Out. | 58.6M | 60.7M | 60.1M | 59.4M | 61.6M | 61.6M |
| Valuation | ||||||
| P/E Ratio | 10.2 | 8.4 | 10.3 | 8.7 | 10.1 | 15.3 |
| P/FCF | 6.5 | 6.9 | 13.9 | 4.7 | 8.6 | 13.0 |
| EV/EBIT | 8.4 | 6.7 | 7.2 | 4.9 | 6.3 | 9.9 |
| Price/Book | 3.7 | 3.1 | 3.5 | 3.2 | 3.1 | 4.8 |
| Price/Sales | 1.7 | 1.9 | 1.9 | 2.0 | 2.0 | 3.0 |
| FCF Yield | 15.3% | 14.5% | 7.2% | 21.2% | 11.7% | 7.7% |
| Market Cap | 110M | 132M | 104M | 107M | 107M | 163M |
| Avg. Price | 1.81 | 2.11 | 1.85 | 1.88 | 1.81 | 2.64 |
| Year-End Price | 1.87 | 2.17 | 1.73 | 1.80 | 1.74 | 2.64 |
NATURHOUSE HEALTH, S.A passes 5 of 9 quality checks, suggesting mixed fundamentals.
NATURHOUSE HEALTH, S.A trades at 15.3x trailing earnings, compared to its 15-year median P/E of 10.1x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 13.0x vs a median of 6.9x. The company's 5-year average ROIC is 69.2% with a gross margin of 71.8%. Total shareholder yield (dividends) is 8.0%. At current prices, the estimated annualized return to fair value is -2.9%.
NATURHOUSE HEALTH, S.A (NTH-MC) has a current P/E ratio of 15.3, compared to its historical median P/E of 10.1. The stock is currently considered Expensive based on its historical valuation range.
NATURHOUSE HEALTH, S.A (NTH-MC) has a 5-year average return on invested capital (ROIC) of 69.2%. This indicates strong capital allocation and a potential competitive advantage.
NATURHOUSE HEALTH, S.A (NTH-MC) has a market capitalization of $163M. It is classified as a small-cap stock.
Yes, NATURHOUSE HEALTH, S.A (NTH-MC) pays a dividend with a trailing twelve-month yield of 7.97%.
Based on historical P/E analysis, NATURHOUSE HEALTH, S.A (NTH-MC) appears expensive. The current P/E of 15.3 is 52% above its historical median of 10.1. The estimated fair value CAGR (P/E method) is -0.2%.
NATURHOUSE HEALTH, S.A (NTH-MC) reported annual revenue of $53 million in its most recent fiscal year, based on SEC EDGAR filings.
NATURHOUSE HEALTH, S.A (NTH-MC) has a net profit margin of 20.0%. This is a healthy margin.
NATURHOUSE HEALTH, S.A (NTH-MC) generated $12 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
NATURHOUSE HEALTH, S.A (NTH-MC) has a debt-to-equity ratio of 0.14. This indicates a conservatively financed balance sheet.
NATURHOUSE HEALTH, S.A (NTH-MC) reported earnings per share (EPS) of $0.17 in its most recent fiscal year.
NATURHOUSE HEALTH, S.A (NTH-MC) has a return on equity (ROE) of 31.1%. This indicates the company generates strong returns for shareholders.
NATURHOUSE HEALTH, S.A (NTH-MC) has a 5-year average gross margin of 71.8%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 5 years of financial data for NATURHOUSE HEALTH, S.A (NTH-MC), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
NATURHOUSE HEALTH, S.A (NTH-MC) has a book value per share of $0.56, based on its most recent annual SEC filing.